{"schema_version":"secwatch.filing_event.v1","accession":"0001663577-25-000317","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.867957+00:00","generated_at":"2026-05-16T19:42:24.937392+00:00","sec_items":["5.02","8.01"],"event_type":"other","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Bio-Path warns of going concern doubt, seeks financing; director resigns","bullets":["Director Douglas Morris resigned effective Nov 13, 2025; resignation received Nov 4.","Company seeking financing to fund turnaround; plans to update finance team, engage new PCAOB auditors, hire investment bankers to review biotech portfolio for sale/partnership/M&A.","Warns substantial doubt about ability to continue as going concern if capital raise fails; notes risk of delisting from OTC Markets.","No specifics on financing amount or timeline; strategic review of portfolio and M&A pursuits announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001663577-25-000317","json":"https://secwatch.observer/filing/0001663577-25-000317.json","markdown":"https://secwatch.observer/filing/0001663577-25-000317.md","text":"https://secwatch.observer/filing/0001663577-25-000317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/0001663577-25-000317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/bpth_8k110425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:42:24.937392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}